Blog Posts - Food And Drug Administration



Aντράκλα , ένα παρεξηγημένο φυτό το οποίο έχει χαρακτηριστεί από τους ερευνητές "παγκόσμια πανάκεια"

Αντράκλα , ένα παρεξηγημένο φυτό το οποίο έχει χαρακτηριστεί από τουςερευνητές "παγκόσμια πανάκεια"Η Αντράκλα ή ανδράχλη ή γλυστρίδα (επ...
by THERAPY MEDICINAL HERBS on Aug 19, 2016

Pregnancy and Epilepsy: Risks to the Baby

By Stacey Chillemi and Blanca Vazquez When you have epilepsy, one of your first questions when considering whether to have a baby may be, Is there any risk of birth defects or problems... Learn, support and connect with people who hav...
by EPILEPSY YOU'RE NOT ALONE on Mar 10, 2016

Clinical trials treat epilepsy patients in WNY with medical marijuana

By Ellen GoldbaumFor patients with severe forms of epilepsy that don’t respond to other medications, hopes are high for marijuana as a treatment. But clinical data showing how well the drug works —... Learn, support and connect with people who h...
by EPILEPSY YOU'RE NOT ALONE on Jan 21, 2016

Cardiac Issues Associated with High-Dose Drug Trial

Last week, Teva Pharmaceutical Industries Ltd. and Active Biotech AB announced they were ending the higher-dose portions of two multiple-sclerosis medication studies. The decision came after eight patients suffered nonfatal... Read More The...
by Zintro Blog on Jan 21, 2016

The Marijuana Project: a novel about medicine and morality

The inspiration for Brian Laslow’s fiction-based-on-fact story, The Marijuana Project (SDS Publishing), came from his own turbulent experiences while working with a brand new medical marijuana... Learn, support and connect with people who have epi...
by EPILEPSY YOU'RE NOT ALONE on Dec 15, 2015

FDA Extends Compliance Date for Menu-Labeling Rule

Last month, the FDA extended the compliance date for its controversial menu-labeling rule from Dec. 1, 2015 to Dec. 1, 2016. The new requirements apply to restaurants and similar retail... Read More The post FDA Extends Compliance Date for...
by Zintro Blog on Sep 1, 2015

FDA Approves First 3D Printed Drug

The U.S. Food and Drug Administration (FDA) approved the first 3D-printed drug this month, Spritam, designed to treat seizures brought on by epilepsy in children and adults. It was developed... Read More The post FDA Approves First 3D Print...
by Zintro Blog on Aug 27, 2015

FDA Approves OxyContin for Children Ages 11 to 16

Nearly one in 25 high school students have abused OxyContin, a study found. Recently, the Food and Drug Administration approved OxyContin to be used by children ages 11 to 16 for pain “severe enough to require daily, around-the-clock, long term...
by Recovery Advocates on Aug 18, 2015

Nordstrom (JWN) Bullish Expectations; Onconova (ONTX) Soars on FDA Submission for HR-MDS Drug

Nordstrom Inc. (JWN) The price of JWN stock surged more than 5% in after-hours trading Thursday as the company delivered quarterly profit numbers above Wall Street analysts’ expectations For its second quarter 2015, JWN posted net sales of $3.6...
by CRWE-PR Finance on Aug 14, 2015

FDA Deems Cigarettes ‘Self Harm Tools'; Smokers to be Placed on “At Risk Individuals” List

MARYLAND – An unprecedented ruling by the Federal Drug Administration has found cigarettes to be self-harm tools akin to razor blades for the angst-driven teen. Stating that smokers are, “basically attention whores willing to kill themsel...
by The Daily F**king News on Aug 13, 2015

Unrant helps a record number of internet surfers following the launch of Hyperhidrosis Advice

FOR IMMEDIATE RELEASE Free Press Release Submitted by unrant.com       Press Release Distribution Milwaukee, WI – As their site continues to grow larger and larger, Unrant is continuing to raise the bar in helping people wit...
by Free PR Online on Jul 24, 2015

Strong Momentum Signals: Inotek Pharmaceuticals (ITEK), Cara Therapeutics (CARA)

Inotek Pharmaceuticals Corp. (ITEK) The price of ITEK stock skyrocketed more than 50% in early trading Thursday as the company announced that the Phase 3 development strategy of its lead glaucoma drug, trabodenoson, a first-in-class selective adenosi...
by CRWE-PR Finance on Jul 23, 2015

Charles Frischer Bets on Newcastle Investment (NCT); Cantor Sees Upside Potential in Relypsa (RLYP)

Newcastle Investment Corp. (NCT) Charles Frischer disclosed in a regulatory filing ( SC 13D ) with the Securities and Exchange Commission (SEC) a 5.2% (3,442,000 shares) stake in NCT. NCT reported a key measure of profitability in its first quarter 2...
by CRWE-PR Finance on Jul 7, 2015

Hansen Medical (HNSN) and Tesla Motors (TSLA) Momentum Signals; Progress Software (PRGS) Surpasses Forecasts

Hansen Medical, Inc. (HNSN) After the closing bell on Wednesday, HNSN said that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Magellan(TM) 10Fr Robotic Catheter for use in the peripheral vasculature. HNSN‘s Magell...
by CRWE-PR Finance on Jul 2, 2015

GW Pharma (GWPH) New High, Momentum Factors; BTIG Research Strong Perspective on Netflix (NFLX)

GW Pharmaceuticals plc (GWPH) Shares of GWPH surged to touch an all-time high of $129.62 on Monday’s trading session. GWPH recently commenced the second of two Phase 3 clinical trials of Epidiolex(R) (cannabidiol or CBD) for the treatment of Le...
by CRWE-PR Finance on Jun 23, 2015

Aerie Pharma (AERI) Soars on FDA- Feedback; Buffett’s Berkshire (BRK.A) (BRK.B) Makes Strategic Move

Aerie Pharmaceuticals, Inc. (AERI) Shares of AERI soared more than 40% in after-hours trading Monday as the company said that the U.S. Food and Drug Administration (FDA) has agreed in written and verbal communications that AERI may change the primary...
by CRWE-PR Finance on Jun 16, 2015

St. Jude Medical (STJ) FDA OKs Brain Implant for Parkinson’s Symptoms; Charles Schwab (SCHW) PT Boosted

 St. Jude Medical Inc. (STJ) The U.S. Food and Drug Administration (FDA) has approved STJ‘s Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential tremo...
by CRWE-PR Finance on Jun 13, 2015

FDA Approves Brain Implant to Help Reduce Parkinson’s Disease and Essential Tremor Symptoms

Las Vegas, NV / CRWEPRESSRELEASE / June 12, 2015 / The U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential...
by CRWE-PR Finance on Jun 12, 2015

GW Pharmaceuticals Initiates Second Phase 3 Pivotal Study of Epidiolex(R) (CBD) in Lennox-Gastaut Syndrome

London, UK / CRWEPRESSRELEASE / 11 June 2015 / GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics fr...
by CRWE-PR Finance on Jun 11, 2015

Aoxing Pharmaceutical (AXN) Breathtaking Momentum; HealthEquity (HQY) Robust Growth Metrics

Aoxing Pharmaceutical Company, Inc. (AXN) Shares of AXN soared to touch a new 52-week high in after-hours trading Monday as the company announced that the China Food and Drug Administration has issued to its subsidiary licenses to produce pain-manage...
by CRWE-PR Finance on Jun 9, 2015


Trending Topics

Close